Assignee
REISTONE BIOPHARMA COMPANY LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0160US2025361226A1Pharmaceutically acceptable salt of benzo[c]chroman compound and polymorphic form and use of pharmaceutically acceptable saltREISTONE BIOPHARMA COMPANY LTD·Filed 2023·Application pending·0 cites
- 0259US2025353839A1Polymorph of benzo[c]chroman compound, preparation method therefor and use thereofREISTONE BIOPHARMA COMPANY LTD·Filed 2023·Application pending·0 cites
- 0347US2024083921A1Borate derivative and uses thereofREISTONE BIOPHARMA COMPANY LTD·Filed 2021·Application pending·0 cites
- 0440US2024083888A1Small molecule inhibitor for cathepsin c and medicinal use thereofREISTONE BIOPHARMA COMPANY LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REISTONE BIOPHARMA COMPANY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →